Your risk of developing a blood clot is higher than usual while you are immobile as your foot is in a cast or you are unable to place weight on it, and you have at least one of the risks listed above. Taking Rivaroxaban will reduce the risk of developing a blood clot.
Rivaroxaban is often used to prevent blood clots after hip/knee replacement surgery and in patients with an irregular heartbeat. It is also sometimes given as a treatment to people who have had recent blood clots, in order to stop new ones forming. However, it is not yet approved to prevent blood clots in patients with lower limb casts or those unable to weight-bear after foot and ankle surgery. It is important to note that this does not mean that it doesn’t work when patients have a cast, but rather that no large-scale studies have been done to assess this as yet.
One possible alternative treatment to Rivaroxaban is a type of medicine called Low Molecular Weight Heparin (LMWH). LMWHs have been used for a number of years but have to be injected daily and may be associated with other complications which require regular blood tests to monitor.
At RNOH, senior doctors and pharmacists have reviewed the data surrounding Rivaroxaban. Given that Rivaroxaban is effective in preventing and treating blood clots in a number of related situations, it has been deemed that it is safe to use Rivaroxaban in patients undergoing foot and ankle surgery. This is known as ‘off-label’ use.
Please talk to your surgical team or ward pharmacist if you have any concerns about taking Rivaroxaban. Any newly started medication will be checked by a pharmacist to ensure the medicine is right for you.